CD300ld promotes neutrophil bacterial phagocytosis in sepsis

Yuichi Akama1, Atsushi Murao1, Monowar Aziz1,2

  • 1Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, NY 11030, United States.

PubMed

Insights

CD300 antigen-like family member d (CD300ld) on neutrophils is crucial for fighting sepsis. Activating CD300ld enhances bacterial clearance, reducing sepsis severity and organ damage in mice.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Sepsis involves a dangerous immune response to infection, impairing neutrophil function.
  • CD300 antigen-like family member d (CD300ld) on neutrophils is linked to phagocytosis via the Fc receptor common gamma-chain (FcRγ chain).

Purpose of the Study:

  • To investigate the role of CD300ld in neutrophil phagocytosis and its impact on sepsis.
  • To explore CD300ld as a potential therapeutic target for sepsis.

Main Methods:

  • Measured CD300ld expression in neutrophils from septic mice and patients.
  • Performed transcriptomic analysis of CD300ld knock-out neutrophils.
  • Stimulated neutrophils with CD300ld agonist antibodies.
  • Assessed bacterial phagocytosis in vitro and in vivo.
  • Evaluated sepsis outcomes in mice receiving CD300ld-activated neutrophils.

Main Results:

  • CD300ld expression decreased in neutrophils during sepsis.
  • CD300ld expression positively correlated with bacterial phagocytosis.
  • CD300ld deficiency impaired bacterial defense gene expression.
  • CD300ld activation enhanced neutrophil phagocytosis of E. coli and S. aureus.
  • Adoptive transfer of CD300ld-activated neutrophils reduced bacterial load, inflammation, and organ injury in septic mice.

Conclusions:

  • CD300ld is a critical regulator of neutrophil phagocytosis and bacterial clearance in sepsis.
  • CD300ld signaling represents a promising target for novel sepsis immunotherapies.

Related Concept Videos